{"database": "lobbying", "table": "lobbying_activities", "rows": [[2681965, "ac9135ec-f406-4f71-9208-dc0fc7d181df", "Q3", "GREENBERG TRAURIG, LLP", 16896, "LIFE MOLECULAR IMAGING (F/K/A PIRAMAL IMAGING LIMITED)", 2021, "third_quarter", "SCI", "Administrative and legislative monitoring and outreach related to Alzheimers Disease research funding. \nAdministrative and legislative monitoring and outreach related to pass-through payments for clinical trials. \nDraft Revision, Medicare Diagnostic Radiopharmaceutical Payment Equity Act.\nH.R. 4479, Facilitating Innovative Nuclear Diagnostics Act of 2021.\nS. 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES", 20000, null, 0, 0, "2021-10-15T15:44:26.697000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2681965"], "units": {}, "query_ms": 1.2493400136008859, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}